The Valley Desk

NCT03054428 · Interventional trial

Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis

Overall registry status Completed

Phase 3

Conditions Dermatitis, Atopic, Dermatitis, Dermatitis Atopic, Disease, Eczematous Skin, Diseases Genetic, Genetic, Diseases Inborn, Skin, Eczema, Skin Diseases, Skin, Hypersensitivity, Immediate, Hypersensitivity, Immune System Diseases, Moderate-to-Severe Atopic Dermatitis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov